134 related articles for article (PubMed ID: 8603539)
21. Inhibition by rapamycin of PDGF- and bFGF-induced human tenon fibroblast proliferation in vitro.
Salas-Prato M; Assalian A; Mehdi AZ; Duperré J; Thompson P; Brazeau P
J Glaucoma; 1996 Feb; 5(1):54-9. PubMed ID: 8795734
[TBL] [Abstract][Full Text] [Related]
22. Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.
Terabe F; Kitano M; Kawai M; Kuwahara Y; Hirano T; Arimitsu J; Hagihara K; Shima Y; Narazaki M; Tanaka T; Kawase I; Sano H; Ogata A
Mod Rheumatol; 2009; 19(5):522-9. PubMed ID: 19568828
[TBL] [Abstract][Full Text] [Related]
23. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells.
Graves LM; Bornfeldt KE; Argast GM; Krebs EG; Kong X; Lin TA; Lawrence JC
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7222-6. PubMed ID: 7638171
[TBL] [Abstract][Full Text] [Related]
24. Thrombin in the synovial fluid of patients with rheumatoid arthritis mediates proliferation of synovial fibroblast-like cells by induction of platelet derived growth factor.
Ohba T; Takase Y; Ohhara M; Kasukawa R
J Rheumatol; 1996 Sep; 23(9):1505-11. PubMed ID: 8877916
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
26. The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites.
Ferrari S; Pearson RB; Siegmann M; Kozma SC; Thomas G
J Biol Chem; 1993 Aug; 268(22):16091-4. PubMed ID: 8344891
[TBL] [Abstract][Full Text] [Related]
27. Platelet-Derived Growth Factor Receptor Activation Promotes the Prodestructive Invadosome-Forming Phenotype of Synoviocytes from Patients with Rheumatoid Arthritis.
Charbonneau M; Lavoie RR; Lauzier A; Harper K; McDonald PP; Dubois CM
J Immunol; 2016 Apr; 196(8):3264-75. PubMed ID: 26976956
[TBL] [Abstract][Full Text] [Related]
28. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
29. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase.
Boluyt MO; Zheng JS; Younes A; Long X; O'Neill L; Silverman H; Lakatta EG; Crow MT
Circ Res; 1997 Aug; 81(2):176-86. PubMed ID: 9242178
[TBL] [Abstract][Full Text] [Related]
30. Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts.
Kim G; Jun JB; Elkon KB
Arthritis Rheum; 2002 Jun; 46(6):1504-11. PubMed ID: 12115180
[TBL] [Abstract][Full Text] [Related]
31. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.
Price DJ; Grove JR; Calvo V; Avruch J; Bierer BE
Science; 1992 Aug; 257(5072):973-7. PubMed ID: 1380182
[TBL] [Abstract][Full Text] [Related]
32. Insulin stimulation of mitogen-activated protein kinase, p90rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice. Implications for the regulation of glycogen synthase.
Chang PY; Le Marchand-Brustel Y; Cheatham LA; Moller DE
J Biol Chem; 1995 Dec; 270(50):29928-35. PubMed ID: 8530392
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of proliferation but not erythroid differentiation of J2E cells by rapamycin.
Jaster R; Bittorf T; Klinken SP; Brock J
Biochem Pharmacol; 1996 May; 51(9):1181-5. PubMed ID: 8645341
[TBL] [Abstract][Full Text] [Related]
34. Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
Pohlers D; Huber R; Ukena B; Kinne RW
Arthritis Rheum; 2006 Mar; 54(3):788-94. PubMed ID: 16508943
[TBL] [Abstract][Full Text] [Related]
35. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.
Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H
Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602
[TBL] [Abstract][Full Text] [Related]
36. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
Terada N; Lucas JJ; Szepesi A; Franklin RA; Takase K; Gelfand EW
Biochem Biophys Res Commun; 1992 Aug; 186(3):1315-21. PubMed ID: 1380801
[TBL] [Abstract][Full Text] [Related]
37. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells.
Chaudhary LR; Hruska KA
J Cell Biochem; 2001 Mar; 81(2):304-11. PubMed ID: 11241670
[TBL] [Abstract][Full Text] [Related]
38. Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis.
Chabaud-Riou M; Firestein GS
Am J Pathol; 2004 Jan; 164(1):177-84. PubMed ID: 14695331
[TBL] [Abstract][Full Text] [Related]
39. Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts.
Sandler C; Joutsiniemi S; Lindstedt KA; Juutilainen T; Kovanen PT; Eklund KK
Biochem Biophys Res Commun; 2006 Aug; 347(1):31-5. PubMed ID: 16806061
[TBL] [Abstract][Full Text] [Related]
40. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
Pakozdi A; Amin MA; Haas CS; Martinez RJ; Haines GK; Santos LL; Morand EF; David JR; Koch AE
Arthritis Res Ther; 2006; 8(4):R132. PubMed ID: 16872482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
